Gain Therapeutics (GANX) Cash & Equivalents (2020 - 2026)
Gain Therapeutics (GANX) posted Cash & Equivalents of $13.1 million for Q2 2026, up 95.5% from $6.7 million a year earlier but down 20.8% from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Gain Therapeutics' Cash & Equivalents came in at $20.84 million, up 100.6% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 22.7% (FY2020 to FY2025).
- In prior years, Gain Therapeutics' Cash & Equivalents was $10.39 million in FY2024 (-11.9%), $11.79 million in FY2023 (+61.3%), $7.31 million in FY2022 (-80.2%) and $36.88 million in FY2021 (+392.2%).
- Quarterly Cash & Equivalents has run from a low of $4.27 million in Q3 2023 to a high of $40.98 million in Q3 2021 over five years.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last three quarters, with growth averaging 43.3% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2021, with growth of 392.2%; the weakest was Q1 2023, with a decline of 82.6%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $16.54 million (Q1 2026), $20.84 million (Q4 2025) and $8.81 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Gain Therapeutics | 54.61 Mn | -4.68 Mn | - | 13.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.10 Mn |
| Mar 31, 2026 | 16.54 Mn |
| Dec 31, 2025 | 20.84 Mn |
| Sep 30, 2025 | 8.81 Mn |
| Jun 30, 2025 | 6.70 Mn |
| Mar 31, 2025 | 9.10 Mn |
| Dec 31, 2024 | 10.39 Mn |
| Sep 30, 2024 | 12.05 Mn |
| Jun 30, 2024 | 16.94 Mn |
| Mar 31, 2024 | 10.64 Mn |
| Dec 31, 2023 | 11.79 Mn |
| Sep 30, 2023 | 4.27 Mn |
| Jun 30, 2023 | 6.32 Mn |
| Mar 31, 2023 | 5.99 Mn |
| Dec 31, 2022 | 7.31 Mn |
| Sep 30, 2022 | 10.88 Mn |
| Jun 30, 2022 | 14.31 Mn |
| Mar 31, 2022 | 34.34 Mn |
| Dec 31, 2021 | 36.88 Mn |
| Sep 30, 2021 | 40.98 Mn |
API Access
Gain Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();